Liposomal drug delivery represents a highly adaptable therapeutic platform for treating a
wide range of diseases. Natural and synthetic lipids, as well as surfactants, are commonly …

Strategies used to enhance liposome-mediated drug delivery in vivo include the
enhancement of stability and circulation time in the bloodstream, targeting to specific tissues …

Liposomes are biodegradable and biocompatible lipid bilayer vesicles which are widely
exploited as preferred carriers for smart delivery of both hydrophobic as well as hydrophilic …

A growing amount of literature describes the development and applications of novel
targeting and/or release triggering schemes to improve the therapeutic index of drugs …

Effective delivery of drugs via liposomes in the treatment or prevention of disease is the aim
of numerous researchers worldwide. Therapies include those for cancer, microbial …

Liposomes are the most widely used nanocarrier systems in medicine. Common strategies
for tumor-specific drug delivery using liposomes include the passive accumulation of …

The combination of liposomes with polymeric scaffolds could revolutionize the current state
of drug delivery technology. Although liposomes have been extensively studied as a …

Liposomes are being increasingly utilized to deliver drugs, enzymes, antisense
oligonucleotides, and genes to various therapeutic targets. Liposome-mediated delivery of …

Liposomes are a unique platform for drug delivery, and a number of liposomal formulations
have already been commercialized. Doxil is a representative example, which uses …

Liposomes are self-assembled, closed spherical systems with a lipid bilayer, composed of ia
one or more amphiphilic phospholipids, and widely used in the pharmaceutical, cosmetic …